APO Research
Talk to an analyst

APO RESEARCH · REPORT

Flu Prevention

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Flu Prevention Industry Growth and Trends Forecast to 2032

28 December 2025105 pages

Choose your research edition.

Industry ResearchFlu Prevention Industry Research Report 2026126 pages · $2,950 USDIndustry Growth & TrendsGlobal Flu Prevention Industry Growth and Trends Forecast to 2032105 pages · $3,450 USDMarket StructureGlobal Flu Prevention Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Flu Prevention Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Flu Prevention Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Flu Prevention market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Flu Prevention is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Flu Prevention is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Flu Prevention is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Flu Prevention include AstraZeneca, BCHT, CSL, KM Biologics, Sinovac, GSK, Hualan Bio, Viatris and Jiangsu GDK, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Flu Prevention market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Flu Prevention market size, estimates, and forecasts are presented in terms of sales volume (M Doses) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Flu Prevention market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Flu Prevention.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Flu Prevention market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Flu Prevention Market by Company

AstraZeneca

BCHT

CSL

KM Biologics

Sinovac

GSK

Hualan Bio

Viatris

Jiangsu GDK

Sanofi

Changchun Institute of Biological

Flu Prevention Segment by Type

Trivalent Influenza Vaccine

Quadrivalent Influenza Vaccine

Flu Prevention Segment by Application

6 Months to 3 Years

> 3 Years

Flu Prevention Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Flu Prevention market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Flu Prevention and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Flu Prevention.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Flu Prevention manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Flu Prevention in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Trivalent Influenza Vaccine Table 2. Major Company of Quadrivalent Influenza Vaccine Table 3. Global Flu Prevention Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Flu Prevention Sales by Type (2021-2026) & (M Doses) Table 5. Global Flu Prevention Sales Market Share in Volume by Type (2021-2026) Table 6. Global Flu Prevention Sales by Type (2021-2026) & (US$ Million) Table 7. Global Flu Prevention Sales Market Share in Value by Type (2021-2026) Table 8. Global Flu Prevention Price by Type (2021-2026) & (US$/Unit) Table 9. Global Flu Prevention Sales by Type (2027-2032) & (M Doses) Table 10. Global Flu Prevention Sales Market Share in Volume by Type (2027-2032) Table 11. Global Flu Prevention Sales by Type (2027-2032) & (US$ Million) Table 12. Global Flu Prevention Sales Market Share in Value by Type (2027-2032) Table 13. Global Flu Prevention Price by Type (2027-2032) & (US$/Unit) Table 14. North America Flu Prevention Sales by Type (2021-2026) & (M Doses) Table 15. North America Flu Prevention Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Flu Prevention Sales by Type (2021-2026) & (M Doses) Table 17. Europe Flu Prevention Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Flu Prevention Sales by Type (2021-2026) & (M Doses) Table 19. Asia-Pacific Flu Prevention Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Flu Prevention Sales by Type (2021-2026) & (M Doses) Table 21. Latin America Flu Prevention Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Flu Prevention Sales by Type (2021-2026) & (M Doses) Table 23. Middle East and Africa Flu Prevention Sales by Type (2021-2026) & (US$ Million) Table 24. Flu Prevention Industry Trends Table 25. Flu Prevention Industry Drivers Table 26. Flu Prevention Industry Opportunities and Challenges Table 27. Flu Prevention Industry Restraints Table 28. Global Flu Prevention Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Flu Prevention Revenue Market Share by Company (2021-2026) Table 30. Global Flu Prevention Sales by Company (2021-2026) & (M Doses) Table 31. Global Flu Prevention Sales Share by Company (2021-2026) Table 32. Global Flu Prevention Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global Flu Prevention Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Flu Prevention Major Company Production Sites and Headquarters Table 35. Global Flu Prevention Company, Product Type & Application Table 36. Global Flu Prevention Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Flu Prevention by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Flu Prevention Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Flu Prevention Sales by Region (2021-2026) & (M Doses) Table 41. Global Flu Prevention Sales Market Share in Volume by Region (2021-2026) Table 42. Global Flu Prevention Sales by Region (2021-2026) & (US$ Million) Table 43. Global Flu Prevention Sales Market Share in Value by Region (2021-2026) Table 44. Global Flu Prevention Sales (M Doses), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global Flu Prevention Sales by Region (2027-2032) & (M Doses) Table 46. Global Flu Prevention Sales Market Share in Volume by Region (2027-2032) Table 47. Global Flu Prevention Sales by Region (2027-2032) & (US$ Million) Table 48. Global Flu Prevention Sales Market Share in Value by Region (2027-2032) Table 49. Global Flu Prevention Sales (M Doses), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global Flu Prevention Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Flu Prevention Sales by Application (2021-2026) & (M Doses) Table 52. Global Flu Prevention Sales Market Share in Volume by Application (2021-2026) Table 53. Global Flu Prevention Sales by Application (2021-2026) & (US$ Million) Table 54. Global Flu Prevention Sales Market Share in Value by Application (2021-2026) Table 55. Global Flu Prevention Price by Application (2021-2026) & (US$/Unit) Table 56. Global Flu Prevention Sales by Application (2027-2032) & (M Doses) Table 57. Global Flu Prevention Sales Market Share in Volume by Application (2027-2032) Table 58. Global Flu Prevention Sales by Application (2027-2032) & (US$ Million) Table 59. Global Flu Prevention Sales Market Share in Value by Application (2027-2032) Table 60. Global Flu Prevention Price by Application (2027-2032) & (US$/Unit) Table 61. North America Flu Prevention Sales by Application (2021-2026) & (M Doses) Table 62. North America Flu Prevention Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Flu Prevention Sales by Application (2021-2026) & (M Doses) Table 64. Europe Flu Prevention Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Flu Prevention Sales by Application (2021-2026) & (M Doses) Table 66. Asia-Pacific Flu Prevention Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Flu Prevention Sales by Application (2021-2026) & (M Doses) Table 68. Latin America Flu Prevention Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Flu Prevention Sales by Application (2021-2026) & (M Doses) Table 70. Middle East and Africa Flu Prevention Sales by Application (2021-2026) & (US$ Million) Table 71. AstraZeneca Company Information Table 72. AstraZeneca Business Overview Table 73. AstraZeneca Flu Prevention Sales (M Doses), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. AstraZeneca Flu Prevention Product Portfolio Table 75. AstraZeneca Recent Development Table 76. BCHT Company Information Table 77. BCHT Business Overview Table 78. BCHT Flu Prevention Sales (M Doses), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. BCHT Flu Prevention Product Portfolio Table 80. BCHT Recent Development Table 81. CSL Company Information Table 82. CSL Business Overview Table 83. CSL Flu Prevention Sales (M Doses), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. CSL Flu Prevention Product Portfolio Table 85. CSL Recent Development Table 86. KM Biologics Company Information Table 87. KM Biologics Business Overview Table 88. KM Biologics Flu Prevention Sales (M Doses), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. KM Biologics Flu Prevention Product Portfolio Table 90. KM Biologics Recent Development Table 91. Sinovac Company Information Table 92. Sinovac Business Overview Table 93. Sinovac Flu Prevention Sales (M Doses), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Sinovac Flu Prevention Product Portfolio Table 95. Sinovac Recent Development Table 96. GSK Company Information Table 97. GSK Business Overview Table 98. GSK Flu Prevention Sales (M Doses), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. GSK Flu Prevention Product Portfolio Table 100. GSK Recent Development Table 101. Hualan Bio Company Information Table 102. Hualan Bio Business Overview Table 103. Hualan Bio Flu Prevention Sales (M Doses), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Hualan Bio Flu Prevention Product Portfolio Table 105. Hualan Bio Recent Development Table 106. Viatris Company Information Table 107. Viatris Business Overview Table 108. Viatris Flu Prevention Sales (M Doses), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. Viatris Flu Prevention Product Portfolio Table 110. Viatris Recent Development Table 111. Jiangsu GDK Company Information Table 112. Jiangsu GDK Business Overview Table 113. Jiangsu GDK Flu Prevention Sales (M Doses), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 114. Jiangsu GDK Flu Prevention Product Portfolio Table 115. Jiangsu GDK Recent Development Table 116. Sanofi Company Information Table 117. Sanofi Business Overview Table 118. Sanofi Flu Prevention Sales (M Doses), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 119. Sanofi Flu Prevention Product Portfolio Table 120. Sanofi Recent Development Table 121. Changchun Institute of Biological Company Information Table 122. Changchun Institute of Biological Business Overview Table 123. Changchun Institute of Biological Flu Prevention Sales (M Doses), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 124. Changchun Institute of Biological Flu Prevention Product Portfolio Table 125. Changchun Institute of Biological Recent Development Table 126. North America Flu Prevention Market Size Growth Rate (CAGR) by Country (M Doses): 2021 VS 2025 VS 2032 Table 127. North America Flu Prevention Sales by Country (2021-2026) & (M Doses) Table 128. North America Flu Prevention Sales Market Share by Country (2021-2026) Table 129. North America Flu Prevention Sales Forecast by Country (2027-2032) & (M Doses) Table 130. North America Flu Prevention Sales Market Share Forecast by Country (2027-2032) Table 131. North America Flu Prevention Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 132. North America Flu Prevention Market Size by Country (2021-2026) & (US$ Million) Table 133. North America Flu Prevention Market Share by Country (2021-2026) Table 134. North America Flu Prevention Market Size Forecast by Country (2027-2032) & (US$ Million) Table 135. North America Flu Prevention Market Share Forecast by Country (2027-2032) Table 136. Europe Flu Prevention Market Size Growth Rate (CAGR) by Country (M Doses): 2021 VS 2025 VS 2032 Table 137. Europe Flu Prevention Sales by Country (2021-2026) & (M Doses) Table 138. Europe Flu Prevention Sales Market Share by Country (2021-2026) Table 139. Europe Flu Prevention Sales Forecast by Country (2027-2032) & (M Doses) Table 140. Europe Flu Prevention Sales Market Share Forecast by Country (2027-2032) Table 141. Europe Flu Prevention Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 142. Europe Flu Prevention Market Size by Country (2021-2026) & (US$ Million) Table 143. Europe Flu Prevention Market Share by Country (2021-2026) Table 144. Europe Flu Prevention Market Size Forecast by Country (2027-2032) & (US$ Million) Table 145. Europe Flu Prevention Market Share Forecast by Country (2027-2032) Table 146. Asia-Pacific Flu Prevention Market Size Growth Rate (CAGR) by Country (M Doses): 2021 VS 2025 VS 2032 Table 147. Asia-Pacific Flu Prevention Sales by Country (2021-2026) & (M Doses) Table 148. Asia-Pacific Flu Prevention Sales Market Share by Country (2021-2026) Table 149. Asia-Pacific Flu Prevention Sales Forecast by Country (2027-2032) & (M Doses) Table 150. Asia-Pacific Flu Prevention Sales Market Share Forecast by Country (2027-2032) Table 151. Asia-Pacific Flu Prevention Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 152. Asia-Pacific Flu Prevention Market Size by Country (2021-2026) & (US$ Million) Table 153. Asia-Pacific Flu Prevention Market Share by Country (2021-2026) Table 154. Asia-Pacific Flu Prevention Market Size Forecast by Country (2027-2032) & (US$ Million) Table 155. Asia-Pacific Flu Prevention Market Share Forecast by Country (2027-2032) Table 156. Latin America Flu Prevention Market Size Growth Rate (CAGR) by Country (M Doses): 2021 VS 2025 VS 2032 Table 157. Latin America Flu Prevention Sales by Country (2021-2026) & (M Doses) Table 158. Latin America Flu Prevention Sales Market Share by Country (2021-2026) Table 159. Latin America Flu Prevention Sales Forecast by Country (2027-2032) & (M Doses) Table 160. Latin America Flu Prevention Sales Market Share Forecast by Country (2027-2032) Table 161. Latin America Flu Prevention Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 162. Latin America Flu Prevention Market Size by Country (2021-2026) & (US$ Million) Table 163. Latin America Flu Prevention Market Share by Country (2021-2026) Table 164. Latin America Flu Prevention Market Size Forecast by Country (2027-2032) & (US$ Million) Table 165. Latin America Flu Prevention Market Share Forecast by Country (2027-2032) Table 166. Middle East and Africa Flu Prevention Market Size Growth Rate (CAGR) by Country (M Doses): 2021 VS 2025 VS 2032 Table 167. Middle East and Africa Flu Prevention Sales by Country (2021-2026) & (M Doses) Table 168. Middle East and Africa Flu Prevention Sales Market Share by Country (2021-2026) Table 169. Middle East and Africa Flu Prevention Sales Forecast by Country (2027-2032) & (M Doses) Table 170. Middle East and Africa Flu Prevention Sales Market Share Forecast by Country (2027-2032) Table 171. Middle East and Africa Flu Prevention Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 172. Middle East and Africa Flu Prevention Market Size by Country (2021-2026) & (US$ Million) Table 173. Middle East and Africa Flu Prevention Market Share by Country (2021-2026) Table 174. Middle East and Africa Flu Prevention Market Size Forecast by Country (2027-2032) & (US$ Million) Table 175. Middle East and Africa Flu Prevention Market Share Forecast by Country (2027-2032) Table 176. Key Raw Materials Table 177. Raw Materials Key Suppliers Table 178. Flu Prevention Distributors List Table 179. Flu Prevention Customers List Table 180. Research Programs/Design for This Report Table 181. Authors List of This Report Table 182. Secondary Sources Table 183. Primary Sources List of Figures Figure 1. Flu Prevention Image Figure 2. Global Flu Prevention Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Flu Prevention Market Size (2021-2032) & (US$ Million) Figure 4. Global Flu Prevention Sales (2021-2032) & (M Doses) Figure 5. Trivalent Influenza Vaccine Image Figure 6. Global Trivalent Influenza Vaccine Sales YoY Growth (2021-2032) & (M Doses) Figure 7. Quadrivalent Influenza Vaccine Image Figure 8. Global Quadrivalent Influenza Vaccine Sales YoY Growth (2021-2032) & (M Doses) Figure 9. Global Flu Prevention Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Flu Prevention Market Share by Type 2025 VS 2032 Figure 11. North America Flu Prevention Sales Market Share in Volume by Type in 2025 Figure 12. North America Flu Prevention Sales Market Share in Value by Type in 2025 Figure 13. Europe Flu Prevention Sales Market Share in Volume by Type in 2025 Figure 14. Europe Flu Prevention Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Flu Prevention Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Flu Prevention Sales Market Share in Value by Type in 2025 Figure 17. Latin America Flu Prevention Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Flu Prevention Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Flu Prevention Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Flu Prevention Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Flu Prevention Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. 6 Months to 3 Years Image Figure 24. Global 6 Months to 3 Years Sales YoY Growth (2021-2032) & (M Doses) Figure 25. > 3 Years Image Figure 26. Global > 3 Years Sales YoY Growth (2021-2032) & (M Doses) Figure 27. Global Flu Prevention Market Size Overview by Application (2021-2032) & (US$ Million) Figure 28. Global Flu Prevention Market Share by Application 2025 VS 2032 Figure 29. North America Flu Prevention Sales Market Share in Volume by Application in 2025 Figure 30. North America Flu Prevention Sales Market Share in Value by Application in 2025 Figure 31. Europe Flu Prevention Sales Market Share in Volume by Application in 2025 Figure 32. Europe Flu Prevention Sales Market Share in Value by Application in 2025 Figure 33. Asia-Pacific Flu Prevention Sales Market Share in Volume by Application in 2025 Figure 34. Asia-Pacific Flu Prevention Sales Market Share in Value by Application in 2025 Figure 35. Latin America Flu Prevention Sales Market Share in Volume by Application in 2025 Figure 36. Latin America Flu Prevention Sales Market Share in Value by Application in 2025 Figure 37. Middle East and Africa Flu Prevention Sales Market Share in Volume by Application in 2025 Figure 38. Middle East and Africa Flu Prevention Sales Market Share in Value by Application in 2025 Figure 39. North America Flu Prevention Sales by Country: 2021 VS 2025 VS 2032 (M Doses) Figure 40. North America Flu Prevention Sales Share by Country: 2021 VS 2025 VS 2032 Figure 41. North America Flu Prevention Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 42. North America Flu Prevention Market Share by Country: 2021 VS 2025 VS 2032 Figure 43. Europe Flu Prevention Sales by Country: 2021 VS 2025 VS 2032 (M Doses) Figure 44. Europe Flu Prevention Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Flu Prevention Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe Flu Prevention Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Asia-Pacific Flu Prevention Sales by Country: 2021 VS 2025 VS 2032 (M Doses) Figure 48. Asia-Pacific Flu Prevention Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Flu Prevention Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Asia-Pacific Flu Prevention Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Latin America Flu Prevention Sales by Country: 2021 VS 2025 VS 2032 (M Doses) Figure 52. Latin America Flu Prevention Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Flu Prevention Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Latin America Flu Prevention Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Middle East and Africa Flu Prevention Sales by Country: 2021 VS 2025 VS 2032 (M Doses) Figure 56. Middle East and Africa Flu Prevention Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Flu Prevention Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Middle East and Africa Flu Prevention Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Flu Prevention Value Chain Figure 60. Key Raw Materials Price Figure 61. Manufacturing Cost Structure Figure 62. Flu Prevention Production Mode & Process Figure 63. Direct Comparison with Distribution Share Figure 64. Distributors Profiles Figure 65. Years Considered Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • Trivalent Influenza Vaccine
  • Quadrivalent Influenza Vaccine
Applications
  • 6 Months to 3 Years
  • > 3 Years
Companies covered
  • AstraZeneca
  • BCHT
  • CSL
  • KM Biologics
  • Sinovac
  • GSK
  • Hualan Bio
  • Viatris
  • Jiangsu GDK
  • Sanofi
  • Changchun Institute of Biological

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Flu Prevention Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Flu Prevention Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Flu Prevention Market by Type
  6. 1.3.1 Trivalent Influenza Vaccine
  7. 1.3.2 Quadrivalent Influenza Vaccine
  8. 1.4 Global Flu Prevention Market Size by Type
  9. 1.4.1 Global Flu Prevention Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Flu Prevention Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Flu Prevention Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Flu Prevention Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Flu Prevention Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Flu Prevention Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Flu Prevention Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Flu Prevention Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Flu Prevention Industry Trends
  2. 2.2 Flu Prevention Industry Drivers
  3. 2.3 Flu Prevention Industry Opportunities and Challenges
  4. 2.4 Flu Prevention Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Flu Prevention Revenue (2021-2026)
  2. 3.2 Global Top Players by Flu Prevention Sales (2021-2026)
  3. 3.3 Global Top Players by Flu Prevention Price (2021-2026)
  4. 3.4 Global Flu Prevention Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Flu Prevention Major Company Production Sites & Headquarters
  6. 3.6 Global Flu Prevention Company, Product Type & Application
  7. 3.7 Global Flu Prevention Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Flu Prevention Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Flu Prevention Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Flu Prevention Tier 1, Tier 2, and Tier 3
4 Flu Prevention Regional Status and Outlook
  1. 4.1 Global Flu Prevention Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Flu Prevention Historic Market Size by Region
  3. 4.2.1 Global Flu Prevention Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Flu Prevention Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Flu Prevention Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Flu Prevention Forecasted Market Size by Region
  7. 4.3.1 Global Flu Prevention Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Flu Prevention Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Flu Prevention Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Flu Prevention by Application
  1. 5.1 Flu Prevention Market by Application
  2. 5.1.1 6 Months to 3 Years
  3. 5.1.2 > 3 Years
  4. 5.2 Global Flu Prevention Market Size by Application
  5. 5.2.1 Global Flu Prevention Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Flu Prevention Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Flu Prevention Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Flu Prevention Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Flu Prevention Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Flu Prevention Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Flu Prevention Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Flu Prevention Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 AstraZeneca
  2. 6.1.1 AstraZeneca Company Information
  3. 6.1.2 AstraZeneca Business Overview
  4. 6.1.3 AstraZeneca Flu Prevention Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 AstraZeneca Flu Prevention Product Portfolio
  6. 6.1.5 AstraZeneca Recent Developments
  7. 6.2 BCHT
  8. 6.2.1 BCHT Company Information
  9. 6.2.2 BCHT Business Overview
  10. 6.2.3 BCHT Flu Prevention Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 BCHT Flu Prevention Product Portfolio
  12. 6.2.5 BCHT Recent Developments
  13. 6.3 CSL
  14. 6.3.1 CSL Company Information
  15. 6.3.2 CSL Business Overview
  16. 6.3.3 CSL Flu Prevention Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 CSL Flu Prevention Product Portfolio
  18. 6.3.5 CSL Recent Developments
  19. 6.4 KM Biologics
  20. 6.4.1 KM Biologics Company Information
  21. 6.4.2 KM Biologics Business Overview
  22. 6.4.3 KM Biologics Flu Prevention Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 KM Biologics Flu Prevention Product Portfolio
  24. 6.4.5 KM Biologics Recent Developments
  25. 6.5 Sinovac
  26. 6.5.1 Sinovac Company Information
  27. 6.5.2 Sinovac Business Overview
  28. 6.5.3 Sinovac Flu Prevention Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Sinovac Flu Prevention Product Portfolio
  30. 6.5.5 Sinovac Recent Developments
  31. 6.6 GSK
  32. 6.6.1 GSK Company Information
  33. 6.6.2 GSK Business Overview
  34. 6.6.3 GSK Flu Prevention Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 GSK Flu Prevention Product Portfolio
  36. 6.6.5 GSK Recent Developments
  37. 6.7 Hualan Bio
  38. 6.7.1 Hualan Bio Company Information
  39. 6.7.2 Hualan Bio Business Overview
  40. 6.7.3 Hualan Bio Flu Prevention Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Hualan Bio Flu Prevention Product Portfolio
  42. 6.7.5 Hualan Bio Recent Developments
  43. 6.8 Viatris
  44. 6.8.1 Viatris Company Information
  45. 6.8.2 Viatris Business Overview
  46. 6.8.3 Viatris Flu Prevention Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Viatris Flu Prevention Product Portfolio
  48. 6.8.5 Viatris Recent Developments
  49. 6.9 Jiangsu GDK
  50. 6.9.1 Jiangsu GDK Company Information
  51. 6.9.2 Jiangsu GDK Business Overview
  52. 6.9.3 Jiangsu GDK Flu Prevention Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Jiangsu GDK Flu Prevention Product Portfolio
  54. 6.9.5 Jiangsu GDK Recent Developments
  55. 6.10 Sanofi
  56. 6.10.1 Sanofi Company Information
  57. 6.10.2 Sanofi Business Overview
  58. 6.10.3 Sanofi Flu Prevention Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Sanofi Flu Prevention Product Portfolio
  60. 6.10.5 Sanofi Recent Developments
  61. 6.11 Changchun Institute of Biological
  62. 6.11.1 Changchun Institute of Biological Company Information
  63. 6.11.2 Changchun Institute of Biological Business Overview
  64. 6.11.3 Changchun Institute of Biological Flu Prevention Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Changchun Institute of Biological Flu Prevention Product Portfolio
  66. 6.11.5 Changchun Institute of Biological Recent Developments
7 North America by Country
  1. 7.1 North America Flu Prevention Sales by Country
  2. 7.1.1 North America Flu Prevention Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Flu Prevention Sales by Country (2021-2026)
  4. 7.1.3 North America Flu Prevention Sales Forecast by Country (2027-2032)
  5. 7.2 North America Flu Prevention Market Size by Country
  6. 7.2.1 North America Flu Prevention Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Flu Prevention Market Size by Country (2021-2026)
  8. 7.2.3 North America Flu Prevention Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Flu Prevention Sales by Country
  2. 8.1.1 Europe Flu Prevention Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Flu Prevention Sales by Country (2021-2026)
  4. 8.1.3 Europe Flu Prevention Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Flu Prevention Market Size by Country
  6. 8.2.1 Europe Flu Prevention Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Flu Prevention Market Size by Country (2021-2026)
  8. 8.2.3 Europe Flu Prevention Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Flu Prevention Sales by Country
  2. 9.1.1 Asia-Pacific Flu Prevention Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Flu Prevention Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Flu Prevention Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Flu Prevention Market Size by Country
  6. 9.2.1 Asia-Pacific Flu Prevention Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Flu Prevention Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Flu Prevention Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Flu Prevention Sales by Country
  2. 10.1.1 South America Flu Prevention Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Flu Prevention Sales by Country (2021-2026)
  4. 10.1.3 South America Flu Prevention Sales Forecast by Country (2027-2032)
  5. 10.2 South America Flu Prevention Market Size by Country
  6. 10.2.1 South America Flu Prevention Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Flu Prevention Market Size by Country (2021-2026)
  8. 10.2.3 South America Flu Prevention Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Flu Prevention Sales by Country
  2. 11.1.1 Middle East and Africa Flu Prevention Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Flu Prevention Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Flu Prevention Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Flu Prevention Market Size by Country
  6. 11.2.1 Middle East and Africa Flu Prevention Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Flu Prevention Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Flu Prevention Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Flu Prevention Value Chain Analysis
  2. 12.1.1 Flu Prevention Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Flu Prevention Production Mode & Process
  7. 12.2 Flu Prevention Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Flu Prevention Distributors
  10. 12.2.3 Flu Prevention Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst